• Home
  • Investors
  • IR Notice

IR Notice

Notice

2016 Closing Announcement of FY2016

 

2016 Closing Announcement of FY2016

Closing Announcement of FY2016

As of December 31, 2016

(Unit KRW)

Closing Announcement of FY2016 - Account, Amount
AccountAmountAccountAmount
ASSETSLIABILITIES
CURRENT ASSETS1,461,425,176,461CURRENT LIABILITIES2,476,545,193,419
Cash and cash equivalents230,337,600,616Trade and other payables138,056,375,073
Short-term financial instruments970,000,000,000Financial liabilities at fair value through profit or loss1,874,470,943,472
Trade and other receivables75,630,820,228Current financial liabilities403,694,084,360
Inventories164,219,979,645Other current liabilities60,323,790,514
Other financial assets16,289,300,000
Other current assets4,947,475,972NON-CURRENT LIABILITIES974,091,453,352
Long-term trade and other payables2,300,379,825
Long-term borrowings439,363,194,458
Defined benefit obligations5,757,265,062
Deferred tax liabilities526,670,614,007
TOTAL LIABILITIES3,450,636,646,771
NON-CURRENT ASSETS6,071,590,929,883SHAREHOLDERS' EQUITY
Long-term financial instruments8,000,000Share capital165,412,500,000
Investments in associates & joint ventures4,944,356,289,991Capital surplus2,487,313,082,024
Property, plant and equipment1,090,959,765,965Accumulated other comprehensive income(loss)4,947,004,536
Intangible assets14,044,654,106Retained earnings1,424,706,873,013
Other financial assets21,475,000,000
Other non-current assets747,219,821TOTAL SHAREHOLDERS' EQUITY4,082,379,459,573
TOTAL ASSETS7,533,016,106,344TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY7,533,016,106,344

March 24, 2017

SAMSUNG BIOLOGICS CO., LTD.

PRESIDENT & CEO Tae Han Kim

The financial statements present fairly, in all material respects, the financial position of the company as of December 31, 2016 and its financial performance and its cash flows for the years ended December 31, 2016 in accordance with K-IFRS.

  

제6기 결산공고 재무상태표

2016년 12월 31일 현재

(단위 : 원)

제6기 결산공고 재무상태표의 항목은 과목, 금액 이 있습니다.
과목금액과목금액
자산부채
유동자산1,461,425,176,461유동부채2,476,545,193,419
현금및현금성자산230,337,600,616매입채무및기타채무138,056,375,073
단기금융상품970,000,000,000당기손익인식금융부채1,874,470,943,472
매출채권및기타채권75,630,820,228유동성금융부채403,694,084,360
재고자산164,219,979,645기타유동부채60,323,790,514
기타금융자산16,289,300,000
기타유동자산4,947,475,972비유동부채974,091,453,352
매입채무및기타채무2,300,379,825
장기차입금439,363,194,458
확정급여부채5,757,265,062
이연법인세부채526,670,614,007
부채총계3,450,636,646,771
비유동자산6,071,590,929,883자본
장기금융상품8,000,000자본금165,412,500,000
관계기업및공동기업투자4,944,356,289,991자본잉여금2,487,313,082,024
유형자산1,090,959,765,965기타포괄손익누계액4,947,004,536
무형자산14,044,654,106이익잉여금1,424,706,873,013
기타금융자산21,475,000,000
기타비유동자산747,219,821자본총계4,082,379,459,573
자산총계7,533,016,106,344부채및자본총계7,533,016,106,344

위와 같이 공고함

2017년 03월 24일

삼성바이오로직스 주식회사

대표이사 사장 김태한

위 재무상태표를 포함한 재무제표는 한국채택국제회계기준에 따라 중요성의 관점에서 적정하게 작성되었습니다.

​ ​ 

  

2016 Closing Announcement of FY2016

Closing Announcement of FY2016

As of December 31, 2016

(Unit KRW)

Closing Announcement of FY2016 - Account, Amount
AccountAmountAccountAmount
ASSETSLIABILITIES
CURRENT ASSETS1,461,425,176,461CURRENT LIABILITIES2,476,545,193,419
Cash and cash equivalents230,337,600,616Trade and other payables138,056,375,073
Short-term financial instruments970,000,000,000Financial liabilities at fair value through profit or loss1,874,470,943,472
Trade and other receivables75,630,820,228Current financial liabilities403,694,084,360
Inventories164,219,979,645Other current liabilities60,323,790,514
Other financial assets16,289,300,000
Other current assets4,947,475,972NON-CURRENT LIABILITIES974,091,453,352
Long-term trade and other payables2,300,379,825
Long-term borrowings439,363,194,458
Defined benefit obligations5,757,265,062
Deferred tax liabilities526,670,614,007
TOTAL LIABILITIES3,450,636,646,771
NON-CURRENT ASSETS6,071,590,929,883SHAREHOLDERS' EQUITY
Long-term financial instruments8,000,000Share capital165,412,500,000
Investments in associates & joint ventures4,944,356,289,991Capital surplus2,487,313,082,024
Property, plant and equipment1,090,959,765,965Accumulated other comprehensive income(loss)4,947,004,536
Intangible assets14,044,654,106Retained earnings1,424,706,873,013
Other financial assets21,475,000,000
Other non-current assets747,219,821TOTAL SHAREHOLDERS' EQUITY4,082,379,459,573
TOTAL ASSETS7,533,016,106,344TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY7,533,016,106,344

March 24, 2017

SAMSUNG BIOLOGICS CO., LTD.

PRESIDENT & CEO Tae Han Kim

The financial statements present fairly, in all material respects, the financial position of the company as of December 31, 2016 and its financial performance and its cash flows for the years ended December 31, 2016 in accordance with K-IFRS.

  

제6기 결산공고 재무상태표

2016년 12월 31일 현재

(단위 : 원)

제6기 결산공고 재무상태표의 항목은 과목, 금액 이 있습니다.
과목금액과목금액
자산부채
유동자산1,461,425,176,461유동부채2,476,545,193,419
현금및현금성자산230,337,600,616매입채무및기타채무138,056,375,073
단기금융상품970,000,000,000당기손익인식금융부채1,874,470,943,472
매출채권및기타채권75,630,820,228유동성금융부채403,694,084,360
재고자산164,219,979,645기타유동부채60,323,790,514
기타금융자산16,289,300,000
기타유동자산4,947,475,972비유동부채974,091,453,352
매입채무및기타채무2,300,379,825
장기차입금439,363,194,458
확정급여부채5,757,265,062
이연법인세부채526,670,614,007
부채총계3,450,636,646,771
비유동자산6,071,590,929,883자본
장기금융상품8,000,000자본금165,412,500,000
관계기업및공동기업투자4,944,356,289,991자본잉여금2,487,313,082,024
유형자산1,090,959,765,965기타포괄손익누계액4,947,004,536
무형자산14,044,654,106이익잉여금1,424,706,873,013
기타금융자산21,475,000,000
기타비유동자산747,219,821자본총계4,082,379,459,573
자산총계7,533,016,106,344부채및자본총계7,533,016,106,344

위와 같이 공고함

2017년 03월 24일

삼성바이오로직스 주식회사

대표이사 사장 김태한

위 재무상태표를 포함한 재무제표는 한국채택국제회계기준에 따라 중요성의 관점에서 적정하게 작성되었습니다.

​ ​

 

 

제6기 결산공고 재무상태표

2016년 12월 31일 현재

(단위 : 원)

제6기 결산공고 재무상태표의 항목은 과목, 금액 이 있습니다.
과목금액과목금액
자산부채
유동자산1,461,425,176,461유동부채2,476,545,193,419
현금및현금성자산230,337,600,616매입채무및기타채무138,056,375,073
단기금융상품970,000,000,000당기손익인식금융부채1,874,470,943,472
매출채권및기타채권75,630,820,228유동성금융부채403,694,084,360
재고자산164,219,979,645기타유동부채60,323,790,514
기타금융자산16,289,300,000
기타유동자산4,947,475,972비유동부채974,091,453,352
매입채무및기타채무2,300,379,825
장기차입금439,363,194,458
확정급여부채5,757,265,062
이연법인세부채526,670,614,007
부채총계3,450,636,646,771
비유동자산6,071,590,929,883자본
장기금융상품8,000,000자본금165,412,500,000
관계기업및공동기업투자4,944,356,289,991자본잉여금2,487,313,082,024
유형자산1,090,959,765,965기타포괄손익누계액4,947,004,536
무형자산14,044,654,106이익잉여금1,424,706,873,013
기타금융자산21,475,000,000
기타비유동자산747,219,821자본총계4,082,379,459,573
자산총계7,533,016,106,344부채및자본총계7,533,016,106,344

위와 같이 공고함

2017년 03월 24일

삼성바이오로직스 주식회사

대표이사 사장 김태한

위 재무상태표를 포함한 재무제표는 한국채택국제회계기준에 따라 중요성의 관점에서 적정하게 작성되었습니다.

​​ 

제6기 결산공고 재무상태표

2016년 12월 31일 현재

(단위 : 원)

제6기 결산공고 재무상태표의 항목은 과목, 금액 이 있습니다.
과목금액과목금액
자산부채
유동자산1,461,425,176,461유동부채2,476,545,193,419
현금및현금성자산230,337,600,616매입채무및기타채무138,056,375,073
단기금융상품970,000,000,000당기손익인식금융부채1,874,470,943,472
매출채권및기타채권75,630,820,228유동성금융부채403,694,084,360
재고자산164,219,979,645기타유동부채60,323,790,514
기타금융자산16,289,300,000
기타유동자산4,947,475,972비유동부채974,091,453,352
매입채무및기타채무2,300,379,825
장기차입금439,363,194,458
확정급여부채5,757,265,062
이연법인세부채526,670,614,007
부채총계3,450,636,646,771
비유동자산6,071,590,929,883자본
장기금융상품8,000,000자본금165,412,500,000
관계기업및공동기업투자4,944,356,289,991자본잉여금2,487,313,082,024
유형자산1,090,959,765,965기타포괄손익누계액4,947,004,536
무형자산14,044,654,106이익잉여금1,424,706,873,013
기타금융자산21,475,000,000
기타비유동자산747,219,821자본총계4,082,379,459,573
자산총계7,533,016,106,344부채및자본총계7,533,016,106,344

위와 같이 공고함

2017년 03월 24일

삼성바이오로직스 주식회사

대표이사 사장 김태한

위 재무상태표를 포함한 재무제표는 한국채택국제회계기준에 따라 중요성의 관점에서 적정하게 작성되었습니다.​ 

SITE MAP

close
close

PRIVACY POLICY

초점받기 링크 PRIVACY STATEMENT OF SAMSUNG BIOLOGICS CO.LTD

Samsung BioLogics (hereinafter, the “Company”) values users’ personal information, complies with statutory obligation s on protection of personal information such as the Act on Promotion of Information and Communication Network Utilization and Information Protection, etc. and the Act on Protection of Personal Information, and has created a Policy to Handle (Process) Personal Information to protect the users’ right and interest to the maximum extent possible.

Through the Policy to Handle (Process) Personal Information, the Company publicizes its operations on personal information treatment (processing) with particulars such as the types of personal information collected from the users and the purpose of processing such information, the time limit for processing and holding in possession, users’ method to exercise their rights, measures to procure the security, and so on.

Whenever there is a change in the Policy to Handle (Process) Personal Information, including updating, deleting, or adding its contents, whether resulting from any amendment to the relevant statutory sources or the administrative policy or change in the Company’s internal policy, we will post the change on our website at www.samsungbiologics. com so as to keep the users updated.

The Company’s Policy to Handle (Proce ss) Personal Information contains the following:

  • 1. Purpose of collecting and using personal information
  • 2. Types of personal information collected and method of collection
  • 3. Time limit for possessing and using personal information
  • 4. Matters regarding entrustment of personal information
  • 5. Matters on providing personal information to a third party
  • 6. Rights of users and legal representatives and how to exercise such rights
  • 7. Installation and operation of automatic collection of personal information and disallow ance
  • 8. Measures to procure security of personal information
  • 9. Personal information manager and customer complaint center
  • 10. Measures to remedy infringement of rights and interest
  • 11. Amendment to the Policy to Handle (Process) Personal Information
1.Purpose of collecting and using personal information

The Company collects personal information for the following purposes. The pfi will not be used for any other purpose and whenever it is necessary to change the purpose, we will comply with the statutory requirements such as obtaining users’ consents in advance.

  • Customer inquiry (Contact Us)

    Review and reply to the inquiries from users

  • Upload a curriculum vitae (Talent Pool Registration)

    Check employment history, give notices for future recruitment opportunities.

2.Types of personal information collected and method of collection
  • Types of personal information collected
    Collection Item information items include Category, Collection Item, and so on.
    Category Collection Item
    Contact Us,
    Talent Pool
    Required Name, Email Address, Company, Occupation, Country, Areas of Interest
    Optional Job Title, Phone Number

    The following information may be generated and collected in the course of using the service.

    Access long, cookie

  • Method to collect

    Collection through Contact Us, Talent Pool within the Website

    Collection through generated information collection tool (for access long, cookie, etc.)

3.Time limit for possessing and utilizing personal information
  • The time limit that the Company may possess and utilize personal information is as follows.

    Personal information that needs to be collected and utilized inevitably as specifically required by law or regulations, or in order to comply with statutory requirements : As long as it is necessary to keep such information in possession under relevant statute.

    Personal information that needs to be collected and utilized inevitably in order to execute and perform various contracts: Until the purpose of collection/utilization is accomplished.

    Personal information collected and used with the consent of individual user: For the time period consented to.

  • Once time period for possession and utilization of the collected personal informationexpires or the purpose is accomplished, the Company will immediately destroy the personal information. However, the Company may continue to possess it beyond the time limit if deemed necessary under the
4.Entrustment of personal information
  • If, in order to provide better service, it is desirable to entrust the handling of personal information to an independent professional business, the Company will obtain the consent of the owner of information and notify the name of the trustee company and the service to be entrusted.
  • When entrusting personal information processing, the Company will ensure to safeguard the personal information. In particular, we will clearly define in the contract such matters as strict compliance with instructions for personal information protection, keeping the personal information confidential, prohibition of disclosing the personal information to a third party, liability attribution at an accident, entrustment period, return or destruction of personal information after the completion of the processing, which will be recorded in paper and/or electronic media.
  • In case of any change in the service contents or in the trustee, we will immediately disclose such change via this Policy to Handle (Process) Personal Information
5.Matters on providing personal information to a third party
  • The Company will not disclose duly collected users’ personal information outside the Company as a matter of principle. However, as follows are the exceptions.

    If the user has given his/her consent in advance.

    If it is specifically required by laws or regulations or inevitable in order to comply with statutory requirements, or if it is deemed necessary for the sake of life, body or property of the information owner or a third party when the information owner or his/her legal representative is under a state incapable of communication or unable to give consent due to unknown domiciles or otherwise (only to the extent the purpose of collecting personal information is served).

  • A user has right to disallow disclosure of his/her personal information to a third party. However, those users who refuse to give consents may have his/her use of the service limited.
6.Rights of users and legal representatives and how to exercise such rights
  • Any user (or his/her legal representative) may withdraw the consent to collection, utilization and conveyance of personal information at any time and may also demand that the following information be tendered for viewing corrected, deleted, or suspended processing, in accordance as prescribed in laws or decrees. Once demanded by a user (or his/her legal representative), the Company will immediately take the appropriate actions, as long as such demand is reasonable and well-grounded.

    User’s personal information

    History of the users personal information being utilized or provided to a third party

    History of consents given to collection, utilization and provision of personal information

  • In any of the following cases, the Company may restrict or refuse to allow access to, tender, correct, delete or suspend processing personal information upon notifying user (or his/her legal representative) of the reason.

    If it is specifically required by laws or regulations or inevitable in order to comply with statutory requirements.

    If it is likely to jeopardize a person’s life or body or unjustly infringe a person’s property or other interests.

  • When the Company decides not to honor a user (or his/her legal representative) demand, we will advise him/her of the fact, reason and process to object the decision in accordance as prescribed in the laws and decrees.
7.Installation and operation of automatic collection of personal information and disallowance

The Company is operating cookies that regularly stores and locates users’ information.

  • Purpose of operating cookies The purpose of the cookie operation is to provide users with optimized information based on the data of users’ website visit and utilization as well as the number of users.
  • Cookie creation, confirmation and how to disallow Each user has the option to allow or disallow cookie installation. By setting an option on the web browser, a user may allow all the cookies, give confirmation every time a cookie is stored, or disallow any cookie storage. However, refusing to allow installation of cookies may lead to some limitation of service to the user.

    How to install cookies (if using Internet explorer 8.0) Select “Internet Option” in the “Tool”. Click “Privacy” tab. Using “Setting”, users may set the level of allowing cookies as suitable for their own needs.

    How to view the cookie received (if using Internet explorer 8.0)

    Select “Internet Option” in the “Tool”. Click “General” tab and select “Setting” of the Browsing History to check the files in “View Files”.

    How to disallow cookie installation (if using Internet explorer 8.0) Select “Internet Option” in the “Tool”. Click “Privacy” tab. Using “Setting”, set it to the higher level, that is, “Block All Cookies”

8.Measures to procure security of personal information

in handling users’personal information, the Company endeavors to keep the personal information from being lost, stolen, revealed, tampered or damaged. To this end, the following technical and managerial actions are taken.

  • Establishment and implementation of internal management plan

    The Company implements its own internal management plan to secure safety in processing the personal information.

    The Company is operating an internal organization dedicated to personal information protection to monitor the status of compliance with the personal information protective requirements and the responsible staff’s duty performance and takes corrective measures when any irregularity is found.

  • Restriction of access to personal information

    Installation and operation of access restriction device Using the intrusion blocking system, the Company controls any unauthorized access from outside and endeavors to procure all the technological system to the maximum extent feasible in order to secure systematic security.

    Minimized designation of personal information processors and education The Company minimizes designation of personal information processors and implements internal and/or outsourced education on a regular basis. Personal information processors’ duty handover is conducted with the security fully maintained and their responsibilities for any personal information accident are clearly defined even after they have left the Company.

    Restrictions on access to personal information The Company places restrictions on access to personal information through granting, changing or revoking the right to access to database system that processes personal information. We also record the history of granting, changing or revoking the right, which are retained for our records for at least three years.

  • Encryption of personal information

    The personal information of users is protected by the password and the file and transmission data are encrypted or stored by using file lock function. More important data are protected through certain separate security measures.

    The Company has adopted security devices that enable safe transmission of personal information on the network using encryption algorithm.

  • Installation and updating of security program

    To safeguard personal information from leak or loss by hackers or computer viruses, the Company has installed a security program and conducts periodic updating and reviewing.

    For unmistakable security operation, every server is installed with intrusion blocking system as a means to block outsider intrusion by hacking as well as a system to analyze vulnerability.

9.Personal information manager and customer complaint center

To protect users’personal information and handle personal information-related customer complaint, the Company has appointed a personal information manager and processor. Any inquiry related to personal information protection and management should be directed to the personal information processor for instant and adequate reply.

  • personal information management (protection) processor

    Division: General Affairs Security Part, Personnel Management Team

    Contact: 032-455-3739

    E-mail: bio.security@samsung.com

10.Measures to remedy infringement of rights and interest

Any user seeking to relief from personal information infringement may apply for resolution or consultation to Personal Information Dispute Mediation Committee, Korea Internet and Security Agency (Personal Information Grievance Center). In addition, users may contact the following institutions to be consulted on personal information infringement cases.

  • Personal Information Dispute Mediation Committee (118)

    Korea Internet and Security Agency (Personal Information Grievance Center)(www.kopico.or.kr/1336)
    Information Protection Mark Verification Committee (http://eprivacy.or.kr/02-580-0533~4)
    Internet Crime Investigation Center of the Supreme Prosecutors’ Office
    (http://icic.sppo.go.kr/02-3480-3600)
    Cyber Police Agency (www.police.go.kr/1566-0112)
    Personal information Protection Committee (http://privacy.kisa.or.kr/kor/main.jsp)/02-2180-3000)

11.Amendment to the Policy to Handle (Process) Personal Information

When this ‘Policy to Handle (Process) Personal Information’ needs to be changed to reflect the change in statutory sources or government policies, we will put such change in public notice through an advisory statement and a separate window on the website.

close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION